Adagio Medical Appoints Two Seasoned Senior Executives to Accelerate Commercial Readiness 
ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
Veteran Healthcare Communicator Lea Sims Appointed to Lead CGFNS Marketing and Communications
PHILADELPHIA, PA / ACCESSWIRE / July 11, 2023 / CGFNS International announced today that it has appointed Lea Sims, a...
Veteran Healthcare Communicator Lea Sims Appointed to Lead CGFNS Marketing and Communications
PHILADELPHIA, PA / ACCESSWIRE / July 11, 2023 / CGFNS International announced today that it has appointed Lea Sims, a...
AlayaCare Welcomes US Health Care Executive Chris Hare as CRO
AlayaCare Bolsters Leadership Team to Accelerate Growth and US ExpansionTORONTO, ON / ACCESSWIRE / July 11, 2023 / AlayaCare, an...
AlayaCare Welcomes US Health Care Executive Chris Hare as CRO
AlayaCare Bolsters Leadership Team to Accelerate Growth and US ExpansionTORONTO, ON / ACCESSWIRE / July 11, 2023 / AlayaCare, an...
Company’s Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness in RSV in a Lethal Lung Disease Animal Model, Reports NanoViricides
SHELTON, CT / ACCESSWIRE / July 11, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a leader in the development...
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
Award Recognizes Efforts to Raise Awareness Around Non-Drug Depression TreatmentMALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
Key GBB Drink Lab Executives to Join Jupiter Wellness’ C-Suite. Josh Wagner and David Sandler Will Bring Their Experience and Knowledge to Jupiter Wellness as it Deploys a Multi-Channel Strategy to Bring Safety Shot to Market
Jupiter Wellness, Inc Jupiter Wellness as it Deploys a Multi-Channel Strategy to Bring Safety Shot to MarketJUPITER, FL, July 11,...
Journey Medical Corporation Announces Positive Topline Results from its Two Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 for the Treatment of Papulopustular Rosacea in Adults
The Phase 3 clinical trials achieved the co-primary and all secondary endpoints and subjects completed the 16-week treatment with no...
Eterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors
CAMBRIDGE, Mass., July 11, 2023 (GLOBE NEWSWIRE) -- Eterna Therapeutics Inc. (Nasdaq: ERNA) (“Eterna” or the “Company”), a life science...
Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings
CHARLOTTESVILLE, Va., July 11, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) ("Adial" or the "Company"), a clinical-stage biopharmaceutical...
Lisata Therapeutics Announces Retirement of Dr. Erkki Ruoslahti from Board of Directors
Lasker Prize winning researcher and serial entrepreneur will remain an advisor to the CompanyBASKING RIDGE, N.J., July 11, 2023 (GLOBE...
Vaxcyte Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants
-- Initiation of Stage 2 Approved by Independent Data Safety Monitoring Board Following Review of Stage 1 Safety and Tolerability...
Salarius Pharmaceuticals Receives FDA Clearance of SP-3164 Investigational New Drug Application to Begin a Phase 1 Clinical Trial in Relapsed/Refractory Non-Hodgkin Lymphoma Patients
The trial will assess the safety and preliminary efficacy of Salarius’ novel targeted protein degrader SP-3164; Patient dosing expected to...
Dr. Fatima Cody Stanford, Associate Professor of Medicine and Pediatrics at Harvard Medical School, Joins Clearmind Medicine’s Scientific Advisory Board
Tel Aviv, Israel/Vancouver, Canada, July 11, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq, CSE: CMND), (FSE: CWY) (“Clearmind” or...
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
MELVILLE, N.Y., July 11, 2023 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX), a clinical...
MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case
MARIETTA, Ga., July 11, 2023 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that...
Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board
Believes that the reduction in radiation exposure the LIBERTY® system could empower more women to pursue careers in Interventional RadiologyHINGHAM,...
McClintock and Amfora Form Strategic Collaboration to Leverage AI to Improve Protein Content of Soy
SAN FRANCISCO, July 11, 2023 (GLOBE NEWSWIRE) -- Artificial intelligence and machine learning innovator McClintock LLC has entered into a...
Celldex Announces Completion of Enrollment in Phase 2 Study of Barzolvolimab in Patients with Chronic Spontaneous Urticaria
HAMPTON, N.J., July 11, 2023 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that patient enrollment has been completed...